Relationship between blood type and outcomes following COVID-19 infection

Young Kim; Christopher A Latz; Charles S DeCarlo; Sujin Lee; C Y Maximilian Png; Pavel Kibrik; Eric Sung; Olamide Alabi; Anahita Dua

doi:10.1053/j.semvascsurg.2021.05.005

Relationship between blood type and outcomes following COVID-19 infection

Semin Vasc Surg. 2021 Sep;34(3):125-131. doi: 10.1053/j.semvascsurg.2021.05.005. Epub 2021 Jul 18.

Authors

Young Kim¹, Christopher A Latz¹, Charles S DeCarlo¹, Sujin Lee¹, C Y Maximilian Png¹, Pavel Kibrik², Eric Sung¹, Olamide Alabi³, Anahita Dua⁴

Affiliations

¹ Division of Vascular and Endovascular Surgery, Harvard Medical School, Massachusetts General Hospital, 55 Fruit Street, Wang 440, Boston, MA, 02114.
² Division of Vascular Surgery, Langone Medical Center, New York University, Brooklyn, NY.
³ Division of Vascular Surgery and Endovascular Therapy, Department of Surgery, Emory University School of Medicine, Atlanta, GA.
⁴ Division of Vascular and Endovascular Surgery, Harvard Medical School, Massachusetts General Hospital, 55 Fruit Street, Wang 440, Boston, MA, 02114. Electronic address: adua1@mgh.harvard.edu.

Abstract

Since the onset of the COVID-19 pandemic, a concentrated research effort has been undertaken to elucidate risk factors underlying viral infection, severe illness, and death. Recent studies have investigated the association between blood type and COVID-19 infection. This article aims to comprehensively review current literature and better understand the impact of blood type on viral susceptibility and outcomes.

Publication types

Review

MeSH terms

COVID-19*
Humans
Pandemics
Risk Factors
SARS-CoV-2